NCT03117946 (i-RTCT) is a NA clinical trial of Biological samples in Lung Cancer, sponsored by Centre Hospitalier Universitaire de Besancon.

Who is sponsoring NCT03117946?

NCT03117946 is sponsored by Centre Hospitalier Universitaire de Besancon.

What drugs are being tested in NCT03117946?

Interventions in NCT03117946: Biological samples.

What condition does NCT03117946 study?

NCT03117946 studies Lung Cancer, Head and Neck Cancer.

Is NCT03117946 still recruiting?

NCT03117946 is currently recruiting now. Last updated 27 December 2024.

Last reviewed 2024-12-27 · How we verify

NCT03117946: i-RTCT

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Modulation of Anti-tumor T Cell Responses in Cancer Patients Treated by Concomitant Radiochemotherapy

Recruiting now NA Last updated 27 December 2024

What this trial tests

NA trial testing Biological samples in Lung Cancer in 220 participants. Currently enrolling.

Timeline

29 May 2017

Primary endpoint
29 August 2026

29 November 2026

Quick facts

Lead sponsor	Centre Hospitalier Universitaire de Besancon
Phase	NA
Status	Recruiting now
Study type	INTERVENTIONAL
Allocation	na
Design	single group
Masking	none
Primary purpose	basic science
Enrollment	220
Start date	29 May 2017
Primary completion	29 August 2026
Estimated completion	29 November 2026
Sites	4 locations across France

Drugs / interventions tested

Biological samples — full drug profile →

Conditions studied

Lung Cancer — all drugs for Lung Cancer →
Head and Neck Cancer — all drugs for Head and Neck Cancer →

Sponsor

Centre Hospitalier Universitaire de Besancon

Who can join

18 and older, any sex, with Lung Cancer or Head and Neck Cancer. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The aim of this study is to evaluate modulation of anti-tumor T cell responses in cancer patients treated by concomitant radiochemotherapy (i-RTCT)

Publications & conference data

2 peer-reviewed publications reference this trial (live from Europe PMC):

Neural influences in colorectal cancer progression and therapeutic strategies.
Zeng Z, Cai S, Ye C, Li T, et al · · 2025 · cited 6× · PMID 40379990 · DOI 10.1007/s00384-025-04887-w
Multidimensional immune profiling uncovers biphasic peripheral T-cell dynamics after chemoradiation in patients with locally advanced head and neck cancer.
Lecoester B, Xie Y, Sun X, Renaudin A, et al · · 2026 · PMID 41749511 · DOI 10.1080/2162402x.2026.2635806

Verify or expand the search:

Other trials of Biological samples

Trials testing the same drug.

NCT07119086 — Factors Associated With Hospitalization and Severity of Arbovirosis in the Indian Ocean · NA · recruiting
NCT06415422 — Platelet Activity Monitoring for Patients Under Adp Medication Using Verify Now in Subdural Hematoma · NA · not yet recruiting
NCT06444503 — Clinico-biological Collection of Bone, Calcium and Growth Plate Pathologies · recruiting
NCT06334406 — Antitumor T Cell Responses in Patients With Bladder Cancer · unknown
NCT06242509 — Intestinal Akkermansia Muciniphila in Prostate Cancer · unknown

Other recruiting trials for Lung Cancer

Currently open trials in the same condition.

NCT07295821 — Osimertinib Induction and Maintenance for Chemo-ineligible Stage III Unresectable EGFR+ NSCLC: Single-arm Study · Phase 2 · recruiting
NCT06909201 — Hyperpolarized Xenon-129 Magnetic Resonance Imaging in Lung Cancer Patients Receiving Radiation Therapy for Investigatin · Phase 1 · recruiting
NCT07524114 — Study of High-Precision Evaluation of Molecular ResiduaL Disease Through a PlatfOrm for Cancer TracKing and Interception · recruiting
NCT07487064 — Galvanize Aliya® EX Pulsed Electric Field (PEF) Treat and Resect Study · NA · recruiting
NCT07146568 — Evaluating the Implementation and Effectiveness of the Pink and Pearl Campaign on Lung Cancer Screening at Christian Hos · NA · recruiting

Other Centre Hospitalier Universitaire de Besancon trials

Trials by the same sponsor.

NCT07492199 — High Depth Exome Sequencing on DNA From a Salivary Sample by Mouth Smear. · not yet recruiting
NCT07438015 — VEXUS-REA : Evaluation of Ultrasound Parameters of Venous Congestion in Patients in a Medical Intensive Care Unit · NA · not yet recruiting
NCT06796114 — Identification of Innovative Biomarkers to Predict Outcomes in Hepatocellular Carcinoma Treated With Tremelimumab and Du · NA · recruiting
NCT06864065 — Study of Emotional Regulation and Underlying Prefrontal Activity in Binge Eating Disorder · NA · recruiting
NCT07067762 — Botulinum Toxin Injections Into the Salivary Glands of Cerebrospinal Children With Chronic Sialorrhea · completed

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT03117946 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Centre Hospitalier Universitaire de Besancon
Last refreshed: 27 December 2024

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03117946.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing